Phase 1 Study in Diabetes Mellitus(Fed)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 15, 2024

Primary Completion Date

June 10, 2024

Study Completion Date

June 10, 2024

Conditions

DiabetesDiabete Mellitus

Interventions

DRUG

HUC2-344

per oral

DRUG

HUC2-344-R1, HUC2-344-R2

per oral

Trial Locations (1)

Huons, Seongnam-si

All Listed Sponsors

lead

Huons Co., Ltd.

INDUSTRY

NCT06551740 - Phase 1 Study in Diabetes Mellitus(Fed) | Biotech Hunter | Biotech Hunter